NDC 49884-321-52 - Olanzapine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49884-321
- Requested NDC
- 49884-321-52
- Package NDCs from labels
- 49884-321-52, 49884-321-55
- Manufacturer
- Par Pharmaceutical, Inc.
- Effective date
- 2021-07-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Olanzapine - Par Pharmaceutical, Inc. | Par Pharmaceutical, Inc. | 2021-07-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Olanzapine - A-S Medication Solutions | A-S Medication Solutions | 2021-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49884-321-52 | EA - Each | 49884-321 | 24ba7eaa-da74-4286-869e-a9d794c4737a | 1 | 2013-02-13 |
| 49884-321-55 | EA - Each | 49884-321 | c3e092d2-7419-4730-bc87-21186002ad89 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OLANZAPINE | ACTIVE INGREDIENT | N7U69T4SZR | OLANZAPINE TABLET, ORALLY DISINTEGRATING [PAR PHARMACEUTICAL, INC.] | 3 | |
| OLANZAPINE | ACTIVE MOIETY | N7U69T4SZR | OLANZAPINE TABLET, ORALLY DISINTEGRATING [PAR PHARMACEUTICAL, INC.] | 3 | |
| MAGNESIUM SULFATE, UNSPECIFIED | INACTIVE INGREDIENT | DE08037SAB | OLANZAPINE TABLET, ORALLY DISINTEGRATING [PAR PHARMACEUTICAL, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| olanzapine | OLANZAPINE | Bionpharma Inc. | 8f485576-a4c4-45d4-816f-2e59fce9f517 | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | 312076 N7U69T4SZR |
| Berberis Oxalis | BERBERIS OXALIS | Uriel Pharmacy Inc. | ff96d8ab-3860-443a-8417-c82508e436ff | 2026-06-30 | Warnings | DE08037SAB |
| Olanzapine | OLANZAPINE | Unit Dose Solutions, Inc. | 55669a10-93f3-cfd6-e063-6294a90aa0e6 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Unit Dose Solutions, Inc. | 55668be2-62ac-3252-e063-6394a90a40f7 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | REMEDYREPACK INC. | e830f488-c689-40f6-9351-f9c7454ff1ea | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Redpharm Drug | 54adae9e-6781-6a77-e063-6394a90ab5c8 | 2026-06-20 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 549dc142-adcd-99ed-e063-6294a90a37fa | 2026-06-19 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 53e6b4e9-de26-16c3-e063-6294a90a7764 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | REMEDYREPACK INC. | 032e589c-47b1-4eb1-9466-8160297b81e9 | 2026-06-03 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Aurobindo Pharma Limited | 4d768cfe-3b20-4127-95b9-b4151b28afcc | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | 312076 N7U69T4SZR |
| Epsom Salt | MAGNESIUM SULFATE | CVS PHARMACY, INC | 1f9e72dc-a394-420d-8fe8-fc4d0f6906ed | 2026-05-27 | Warnings | DE08037SAB |
| Olanzapine | OLANZAPINE | Coupler LLC | 52b99337-afa8-a6f9-e063-6294a90a2038 | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 52bdaaaf-ab54-99d1-e063-6394a90a521f | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Bryant Ranch Prepack | 4e90e30c-78a1-486f-a13c-f1ff798216be | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 51b508ff-dc55-ff36-e063-6294a90a900f | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 51b64b6d-4676-a637-e063-6394a90a450c | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 518a9400-edb8-6403-e063-6294a90a065d | 2026-05-11 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Golden State Medical Supply, Inc. | a1dfb4e7-4143-4422-b7a7-292e4fd75044 | 2026-04-23 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Wilshire Pharmaceuticals, Inc. | f269929e-c2ff-4288-9d3b-7770bcb5a498 | 2026-04-13 | Warnings, Adverse reactions | DE08037SAB |
| OLANZAPINE | OLANZAPINE | GLENMARK PHARMACEUTICALS INC., USA | 2e709eaf-4116-4ee3-8dff-ace36181d115 | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.